Search for: "Industrial Development Corporation of South Africa, Ltd."
Results 81 - 89
of 89
Sort by Relevance
|
Sort by Date
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy:… [read post]
16 May 2008, 8:03 am
, 20-21 May: US ACI ‘In-house counsel forum on pharmaceutical antitrust’ – Maryland: (Orange Book Blog), 26-27 May : EU Workshop for mediators in IP disputes – Geneva: (IPR-Helpdesk), 27 May: Oliver Rivers to give short talk on ‘spurious precision’ – London: (IP finance), 28 May / 11June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – New… [read post]
2 May 2008, 7:00 am
: (IP Kenya), Kenya: China blames Kenya for buying its fakes: (Afro-IP), South Africa: Microsoft settles with 21 infringing retailers: (Afro-IP), South Africa: Piracy stats unacceptably high, despite improvements: (Afro-IP) Asia IP law in Asia symposium: (Experience Not Logic) Australia Duty to invent? [read post]
28 Apr 2008, 11:00 am
, US CAFC throws out jury patent infringement verdict, raises potentially invalidating prior art: Finisar v DirecTV: (Patent Prospector), (Hal Wegner), (EDTexweblog.com), (Peter Zura's 271 Patent Blog), (IP Law360), (Patently-O), (Patently-O), Global Global - General Further resolution needed to keep IP issues in WTO negotiations: (Intellectual Property Watch), Mobile phone manufacturers seek to control rising IP costs: (Intellectual Property Watch), Managing trade secrets for… [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v… [read post]
15 Mar 2008, 7:00 am
Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa:… [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office releases… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
